Cargando…
1-Benzyl-3-aryl-2-thiohydantoin Derivatives as New Anti-Trypanosoma brucei Agents: SAR and in Vivo Efficacy
[Image: see text] A high throughput screening and subsequent hit validation identified compound 1 as an inhibitor of Trypanosoma brucei parasite growth. Extensive structure–activity relationship optimization based on antiparasitic activity led to the highly potent compounds, 1-(4-fluorobenzyl)-3-(4-...
Autores principales: | Buchynskyy, Andriy, Gillespie, J. Robert, Herbst, Zackary M., Ranade, Ranae M., Buckner, Frederick S., Gelb, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554913/ https://www.ncbi.nlm.nih.gov/pubmed/28835807 http://dx.doi.org/10.1021/acsmedchemlett.7b00230 |
Ejemplares similares
-
Phenotypic Drug Discovery for Human African Trypanosomiasis: A Powerful Approach
por: Buckner, Frederick S., et al.
Publicado: (2020) -
Structures of Trypanosoma brucei Methionyl-tRNA Synthetase with Urea-Based Inhibitors Provide Guidance for Drug Design against Sleeping Sickness
por: Koh, Cho Yeow, et al.
Publicado: (2014) -
An Essential Farnesylated Kinesin in Trypanosoma brucei
por: Engelson, Erin J., et al.
Publicado: (2011) -
Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
por: Planer, Joseph D., et al.
Publicado: (2014) -
In vivo cleavage specificity of Trypanosoma brucei editosome endonucleases
por: Carnes, Jason, et al.
Publicado: (2017)